Stock Report

Download full stock data and analysis for free Last Updated: 10-Nov-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Procter & Gamble Health Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: PGHL | BSE: 500126

₹5,699.50

up-down-arrow ₹-17.00 (-0.30%)

As on 09-Nov-2026IST

Market cap

info icon

₹9,448 Cr

Revenue (TTM)

info icon

₹1,491 Cr

P/E Ratio

info icon

24.9

P/B Ratio

info icon

14.4

Div. Yield

info icon

3.6 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 5.16 17.72 16.05 6.41 7.93
EBIT 56.33 28.11 20.72 17.06 16.97
Net Profit 53.87 25.94 16.09 15.46 15.55
EPS 15.98 25.94 23.81 17.97 17.05
Book Value -- -- -2.37 -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-26Mar-25
EBIT-Margin info 26.2724.3631.7930.5032.30
Net Margin info 19.5018.5625.2122.8824.82
Return on equity info 42.5735.8360.2462.1844.15
Return on Capital info 57.8248.19--84.8658.05
Return on Assets info 22.0316.9139.8041.6530.85
Debt to Equity (x) info ----0.000.000.00

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
--
84.86
58.05
42.52
46.07
Peer Median
--
19.41
21.76
21.89
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

60.24

Higher than Peers by 45.05

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
60.24
62.18
44.15
31.58
33.94
Peer Median
15.19
18.29
17.93
16.42
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

39.80

Higher than Peers by 29.70

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
39.80
41.65
30.85
13.43
11.00
Peer Median
10.10
9.88
12.81
12.32
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

31.79

Higher than Peers by 13.23

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
31.79
30.50
32.30
24.20
24.12
Peer Median
18.57
18.50
18.93
21.21
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

25.21

Higher than Peers by 10.79

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
25.21
22.88
24.82
17.22
18.39
Peer Median
14.42
13.32
14.94
15.51
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
--
22.36
24.40
18.14
19.39
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

16.05

Higher than Peers by 3.92

Year on year growth in net sales

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
16.05
50.72
-18.86
-6.37
10.34
Peer Median
12.13
13.53
10.90
12.68
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

20.72

Lower than Peers by 0.73

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
20.72
42.32
--
-6.06
23.27
Peer Median
21.45
20.72
15.01
20.59
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

16.09

Lower than Peers by 6.49

Year on year growth in profit after tax

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
16.09
39.46
16.63
-12.42
19.19
Peer Median
22.58
18.73
14.80
24.56
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

23.81

Higher than Peers by 3.36

Year on year growth in earnings per share

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
23.81
39.46
16.63
-12.42
19.19
Peer Median
20.45
18.72
14.27
25.59
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
--
-2.37
0.45
-28.71
21.97
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
--
--
--
--
--
Peer Median
0.00
0.05
0.06
0.03
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

2.43

Higher than Peers by 0.47

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
2.43
2.18
2.44
2.39
1.72
Peer Median
1.95
1.90
1.90
2.23
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

1.96

Higher than Peers by 0.48

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
1.96
1.65
1.94
1.90
1.53
Peer Median
1.48
1.40
1.46
1.59
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

899.62

Higher than Peers by 880.52

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
899.62
818.93
725.70
380.61
409.05
Peer Median
19.10
19.02
24.96
45.29
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

11.79

Lower than Peers by 9.85

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
11.79
11.67
15.56
7.41
9.41
Peer Median
21.65
19.75
21.77
20.15
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

1.56

Higher than Peers by 0.85

Sales / Average Total Assets

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
1.56
2.00
1.35
0.84
0.64
Peer Median
0.71
0.74
0.76
0.79
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
--
36.06
40.92
29.14
27.36
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
--
28.65
38.75
35.37
34.37
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
--
181.85
235.41
223.07
206.35
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
--
-117.14
-155.74
-158.56
-144.61
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

24.87

Lower than Peers by 10.59

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
24.87
24.36
36.42
41.71
37.97
Peer Median
35.46
34.26
26.81
37.00
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

14.36

Higher than Peers by 9.84

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
14.36
15.33
16.04
15.83
11.73
Peer Median
4.51
5.12
4.65
5.51
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

3.60

Higher than Peers by 3.10

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
3.60
4.27
2.43
5.15
1.81
Peer Median
0.50
0.50
0.61
0.39
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

17.74

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
17.74
16.41
25.39
25.30
24.12
Peer Median
--
26.17
27.02
32.31
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

9,448

Lower than Peers by 8,828

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
9,448
7,965
8,536
8,383
8,714
Peer Median
18,276
17,931
20,914
24,063
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month